Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

MicroRNA-29 molecule makes brain cells resistant to programmed cell death

Researchers at the University of North Carolina at Chapel Hill have discovered a molecule that can make brain cells resistant to programmed cell death or apoptosis.

19 Jan 2011

Time-lapse technique can show cellular-level changes within deep brain regions: Study

Changes within deep regions of the brain can now be visualized at the cellular level, based on research on mice, which was funded by the National Institutes of Health. Published Sunday in Nature Medicine, the study used a groundbreaking technique to explore cellular-level changes over a period of weeks within deep brain regions, providing a level of detail not possible with previously available methods.

19 Jan 2011

Medtronic recieves conditional approval from FDA to modify CoreValve U.S. Pivotal Clinical Trial

Medtronic, today announced it has received conditional approval from the U.S. Food and Drug Administration to modify its CoreValve U.S. Pivotal Clinical Trial.

19 Jan 2011

Hamilton Academy of Medicine launches campaign to increase awareness about smoking cessation

In honour of National Non-Smoking Week, The Hamilton Academy of Medicine is proud to introduce, It's Hamilton's Time to Quit, a campaign designed to increase awareness about local quitting resources and tools to help the community understand the support that is available, and encourage people to seek the assistance they need to stop smoking.

18 Jan 2011

American Heart Association honors SBUMC with Get With The Guidelines-Stroke Gold Plus Performance Achievement Award

Stony Brook University Medical Center has received the 2009 American Heart Association/American Stroke Association's Get With The Guidelines Stroke Gold Plus Performance Achievement Award.

18 Jan 2011

Women's Health Congress to explore mammography controversy

The ongoing controversy about the appropriate age, frequency, and patient benefit of mammography will be explored at the upcoming 19th Annual Congress on Women's Health, April 1-3, 2011 in Washington DC.

18 Jan 2011

New guideline recommends plasmapheresis usage to treat people with severe relapses in MS, neuropathies

A new guideline from the American Academy of Neurology recommends using plasma exchange to treat people with severe relapses in multiple sclerosis and related diseases, as well as those with certain kinds of nerve disorders known as neuropathies.

18 Jan 2011

Health Canada approves Eli Lilly's BYETTA for treatment of adults with type 2 diabetes

Eli Lilly Canada is pleased to announce the Health Canada approval of BYETTATM for the treatment of adults with type 2 diabetes.

18 Jan 2011

Painkillers and heart attack risk

A new study has shown that taking certain commonly used painkillers for long periods or in high doses increases the risk of heart attacks or strokes. The study comes from researchers from Bern University and is published in the British Medical Journal.

16 Jan 2011

First Round Table Meeting on Metabolomics & Diabetes takes place in Vienna

Metabolomic biomarker research is a young research area that carries great hopes for both medicine and the nutritional sciences, particularly for the early detection of genetically determined diseases.

14 Jan 2011

Merck announces changes in vorapaxar clinical studies

Merck today provided the following statement on the changes to the clinical studies for vorapaxar, one of the Company's investigational cardiovascular medicines, following an announcement from the two academic centers leading the studies of vorapaxar.

14 Jan 2011

American Heart Association urges public to reduce salt intake

The American Heart Association today issued a call to action for the public, health professionals, the food industry and the government to intensify efforts to reduce the amount of sodium Americans consume daily.

14 Jan 2011

Patients on dialysis may face risk of death from atrial fibrillation: Study

The abnormal heart rhythm, atrial fibrillation, is increasingly common in patients on dialysis and is linked to a sharp rise in death, in an already at-risk population, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

14 Jan 2011

American Heart Association proposes new metrics to monitor quality of stroke care

The American Heart Association/American Stroke Association has proposed metrics that healthcare professionals can use to monitor the diagnosis and treatment of patients at stroke centers to help improve the quality of care stroke patients receive.

14 Jan 2011

Medtronic acquires Ardian

Medtronic, today announced that it has completed the acquisition of privately-held Ardian, a developer of catheter-based therapies to treat hypertension and related conditions.

13 Jan 2011

Video submissions invited for the 2011 Neuro Film Festival competition

People who have loved ones affected by a brain disorder or have been affected by a disorder themselves still have the opportunity to share their story by submitting a short video to the 2011 Neuro Film Festival(SM) competition at http://www.neurofilmfestival.com. The deadline for entries is February 15, 2011.

13 Jan 2011

Genetic information from Guthrie cards may serve as valuable resource to diagnose infant diseases

Van Andel Research Institute researchers have developed a method that can yield more information from archived newborn blood that has implications for a vast array of research, including population health studies and answering questions about diseases in infants and children.

13 Jan 2011

Brain cell destroying genetic mechanism responsible for development of AD

Researchers at the University of British Columbia and Vancouver Coastal Health Research Institute have discovered that the genetic mechanism which destroys brain cells is responsible for early development of Alzheimer's Disease in people with Down Syndrome and for development of Alzheimer's Disease in general population - providing a potential new target for drugs that could forestall dementia in people with either condition.

13 Jan 2011

BP-lowering medications provide long-term benefit of reducing death risk from cardiovascular disease

In a study published in December 2010, in Hypertension, a journal of the American Heart Association, investigators have shown that early treatment with blood pressure-lowering medications provides a long-term benefit of reducing the risk of death from cardiovascular disease.

13 Jan 2011

NIH awards VistaGen and NuPotential $500,000 grant to advance iPS stem cell technology

VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.

13 Jan 2011

Stroke News and Research

Further Reading

MicroRNA-29 molecule makes brain cells resistant to programmed cell death

Time-lapse technique can show cellular-level changes within deep brain regions: Study

Medtronic recieves conditional approval from FDA to modify CoreValve U.S. Pivotal Clinical Trial

Hamilton Academy of Medicine launches campaign to increase awareness about smoking cessation

American Heart Association honors SBUMC with Get With The Guidelines-Stroke Gold Plus Performance Achievement Award

Women's Health Congress to explore mammography controversy

New guideline recommends plasmapheresis usage to treat people with severe relapses in MS, neuropathies

Health Canada approves Eli Lilly's BYETTA for treatment of adults with type 2 diabetes

Painkillers and heart attack risk

First Round Table Meeting on Metabolomics & Diabetes takes place in Vienna

Merck announces changes in vorapaxar clinical studies

American Heart Association urges public to reduce salt intake

Patients on dialysis may face risk of death from atrial fibrillation: Study

American Heart Association proposes new metrics to monitor quality of stroke care

Medtronic acquires Ardian

Video submissions invited for the 2011 Neuro Film Festival competition

Genetic information from Guthrie cards may serve as valuable resource to diagnose infant diseases

Brain cell destroying genetic mechanism responsible for development of AD

BP-lowering medications provide long-term benefit of reducing death risk from cardiovascular disease

NIH awards VistaGen and NuPotential $500,000 grant to advance iPS stem cell technology

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News